Free Trial

Angi (ANGI) Financials

Angi logo
$16.05 -0.45 (-2.73%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$16.05 0.00 (0.00%)
As of 07/18/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Angi

Annual Income Statements for Angi

This table shows Angi's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
-1.33 13 -103 77 35 -7.50 -71 -128 -41 36
Consolidated Net Income / (Loss)
-4.00 11 -105 78 35 -5.38 -70 -128 -40 37
Net Income / (Loss) Continuing Operations
-4.00 11 -105 78 35 -4.16 -64 -89 -30 37
Total Pre-Tax Income
-2.24 22 -154 70 34 -19 -94 -95 -28 20
Total Operating Income
-1.57 24 -148 64 39 -6.37 -68 -76 -26 22
Total Gross Profit
338 473 702 1,077 1,280 1,295 1,345 1,427 1,296 1,128
Total Revenue
361 499 736 1,132 1,326 1,468 1,619 1,764 1,359 1,185
Operating Revenue
361 499 736 1,132 1,326 1,468 1,619 1,764 1,359 1,185
Total Cost of Revenue
23 26 34 56 46 173 275 337 63 58
Operating Cost of Revenue
23 26 34 56 46 173 275 337 63 58
Total Operating Expenses
340 449 850 1,013 1,241 1,301 1,413 1,503 1,323 1,106
Selling, General & Admin Expense
87 110 300 323 348 374 395 447 359 320
Marketing Expense
226 307 464 541 733 763 872 890 765 602
Research & Development Expense
17 21 48 61 64 69 71 74 97 95
Depreciation Expense
6.59 8.42 15 24 40 53 59 78 94 86
Amortization Expense
3.84 3.15 23 62 55 43 16 14 7.96 2.60
Total Other Income / (Expense), net
-0.67 -1.59 -5.76 6.12 -5.00 -14 -26 -19 -1.71 -1.81
Interest Expense
0.27 0.89 7.74 12 11 14 23 20 20 20
Other Income / (Expense), net
-0.40 -0.70 1.97 18 6.49 - -2.51 1.17 18 18
Income Tax Expense
1.76 12 -49 -7.48 -1.67 -15 -30 -5.39 1.84 -17
Net Income / (Loss) Discontinued Operations
- - - - - - -6.48 -39 -10 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-2.67 -2.50 -1.41 0.19 0.49 2.12 0.88 0.47 0.63 0.84
Basic Earnings per Share
$0.00 $0.03 ($0.24) $0.16 $0.07 ($0.01) ($0.14) ($0.26) ($0.08) $0.07
Weighted Average Basic Shares Outstanding
- 437.60M 430.61M 483.20M 497.60M 500.05M 501.63M 504.78M 502.03M 498.45M
Diluted Earnings per Share
$0.00 $0.03 ($0.24) $0.15 $0.07 ($0.01) ($0.14) ($0.26) ($0.08) $0.07
Weighted Average Diluted Shares Outstanding
- 437.60M 430.61M 483.20M 497.60M 500.05M 501.63M 504.78M 502.03M 498.45M
Weighted Average Basic & Diluted Shares Outstanding
- 437.60M 430.61M 483.20M 497.60M 500.05M 501.63M 504.78M 502.03M 498.45M

Quarterly Income Statements for Angi

This table shows Angi's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-17 -53 -15 -15 -5.36 -5.56 -1.63 3.76 35 -1.29 15
Consolidated Net Income / (Loss)
-17 -53 -15 -14 -5.29 -5.55 -1.32 4.09 35 -1.29 15
Net Income / (Loss) Continuing Operations
-17 -14 -14 -16 -2.95 2.48 -1.32 4.09 35 -1.29 15
Total Pre-Tax Income
-18 -9.14 -12 -15 -9.01 8.14 2.16 8.72 8.75 0.45 20
Total Operating Income
-11 -9.72 -11 -15 -7.86 7.63 2.72 9.19 7.82 2.17 20
Total Gross Profit
389 313 339 337 338 283 293 301 282 252 233
Total Revenue
498 314 355 352 351 300 305 315 297 268 246
Operating Revenue
498 314 355 352 351 300 305 315 297 268 246
Total Cost of Revenue
109 1.57 17 15 14 17 12 14 15 16 13
Operating Cost of Revenue
109 1.57 17 15 14 17 12 14 15 16 13
Total Operating Expenses
400 323 349 352 345 276 290 292 274 250 213
Selling, General & Admin Expense
128 90 97 93 99 71 86 84 77 73 57
Marketing Expense
234 179 200 209 200 157 157 158 155 131 119
Research & Development Expense
16 19 25 26 21 24 24 25 24 23 27
Depreciation Expense
18 32 25 22 22 24 24 24 18 20 9.95
Total Other Income / (Expense), net
-7.33 0.19 -1.22 0.15 -1.15 0.51 -0.55 -0.47 0.93 -1.72 -0.22
Interest Expense
5.03 5.03 5.03 5.03 5.04 5.04 5.04 5.04 5.05 5.05 5.04
Other Income / (Expense), net
-2.30 - 3.81 5.18 3.89 5.55 4.48 4.57 5.98 3.33 4.83
Income Tax Expense
-0.95 5.30 1.88 0.36 -6.06 5.65 3.48 4.63 -27 1.73 4.68
Net Income / (Loss) Attributable to Noncontrolling Interest
0.04 0.09 0.33 0.22 0.07 0.02 0.31 0.33 0.20 - 0.00
Basic Earnings per Share
($0.03) ($0.11) ($0.03) ($0.03) ($0.01) ($0.01) ($0.03) $0.01 $0.07 ($0.01) $0.30
Weighted Average Basic Shares Outstanding
504.47M 504.78M 506.57M 506.28M 507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M
Diluted Earnings per Share
($0.03) ($0.11) ($0.03) ($0.03) ($0.01) ($0.01) ($0.03) $0.01 $0.07 ($0.01) $0.30
Weighted Average Diluted Shares Outstanding
504.47M 504.78M 506.57M 506.28M 507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M
Weighted Average Basic & Diluted Shares Outstanding
504.47M 504.78M 506.57M 506.28M 507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M

Annual Cash Flow Statements for Angi

This table details how cash moves in and out of Angi's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
-2.12 45 173 234 52 422 -384 -127 53 52
Net Cash From Operating Activities
18 48 42 224 214 188 6.21 27 105 156
Net Cash From Continuing Operating Activities
18 48 42 224 214 188 25 46 94 156
Net Income / (Loss) Continuing Operations
-4.00 11 -105 78 35 -4.16 -64 -89 -30 37
Consolidated Net Income / (Loss)
-4.00 11 -105 78 35 -4.16 -70 -128 -40 37
Net Income / (Loss) Discontinued Operations
- - - - - - -6.48 -39 -10 0.00
Depreciation Expense
6.59 8.42 15 24 40 53 59 78 94 86
Amortization Expense
3.84 3.15 23 62 55 43 16 14 7.96 2.60
Non-Cash Adjustments To Reconcile Net Income
22 27 176 131 142 177 145 171 134 108
Changes in Operating Assets and Liabilities, net
-11 -1.79 -67 -71 -59 -80 -132 -127 -111 -77
Net Cash From Discontinued Operating Activities
- - - - - - -18 -19 11 0.00
Net Cash From Investing Activities
-10 -32 -93 -58 -41 -104 -19 -115 -47 -50
Net Cash From Continuing Investing Activities
-10 -32 -93 -58 -41 -104 -19 -115 -47 -50
Purchase of Property, Plant & Equipment
-10 -17 -27 -47 -69 -52 -70 -115 -48 -50
Purchase of Investments
- 0.00 0.00 -60 0.00 -100 0.00 0.00 -12 0.00
Sale of Property, Plant & Equipment
- - 0.00 10 0.00 0.02 0.00 0.16 0.09 0.08
Divestitures
- - 0.00 3.67 24 0.73 0.75 0.00 1.00 0.00
Sale and/or Maturity of Investments
- - 0.00 35 25 50 50 0.00 13 0.00
Net Cash From Financing Activities
-9.52 29 225 -49 -122 337 -345 -17 -17 -54
Net Cash From Continuing Financing Activities
-9.52 29 225 -49 -122 337 -345 -17 -17 -54
Repayment of Debt
0.00 -11 -185 -18 -15 -34 -220 -0.26 -0.06 -0.01
Repurchase of Common Equity
- - 0.00 0.00 -57 -64 -35 -8.14 -11 -29
Payment of Dividends
0.00 -0.21 -13 -6.06 -0.07 -4.28 -28 0.00 0.00 -16
Other Financing Activities, net
-9.53 -4.31 16 -25 -46 -61 -62 -8.83 -5.99 -9.13
Effect of Exchange Rate Changes
-0.32 - - 0.21 - - -0.05 -1.11 0.54 0.47
Other Net Changes in Cash
- - - 117 - - -44 -20 11 0.00

Quarterly Cash Flow Statements for Angi

This table details how cash moves in and out of Angi's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents
-31 -29 -11 60 -3.76 7.77 -0.71 37 -4.93 21 -30
Net Cash From Operating Activities
4.28 16 21 57 11 16 22 63 31 40 -3.11
Net Cash From Continuing Operating Activities
4.28 35 21 56 8.21 8.94 22 63 31 40 -3.11
Net Income / (Loss) Continuing Operations
-17 -14 -14 -16 -2.95 2.48 -1.32 4.09 35 -1.29 15
Consolidated Net Income / (Loss)
-17 -53 -15 -14 -5.29 -5.55 -1.32 4.09 35 -1.29 15
Depreciation Expense
18 32 25 22 22 24 24 24 18 20 9.95
Non-Cash Adjustments To Reconcile Net Income
41 46 35 38 34 27 30 30 26 22 10
Changes in Operating Assets and Liabilities, net
-40 -31 -28 9.03 -48 -44 -31 4.62 -48 -3.23 -39
Net Cash From Investing Activities
-33 -20 -24 2.05 -14 -11 -13 -13 -12 -13 -12
Net Cash From Continuing Investing Activities
-33 -20 -24 2.05 -14 -11 -13 -13 -12 -13 -12
Purchase of Property, Plant & Equipment
-33 -20 -12 -10 -14 -12 -13 -13 -12 -13 -13
Sale of Property, Plant & Equipment
0.06 -0.06 0.01 0.00 - 0.07 0.01 - - 0.08 0.08
Net Cash From Financing Activities
-2.07 -3.50 -1.38 -6.20 -0.66 -8.75 -10 -13 -24 -6.22 -14
Net Cash From Continuing Financing Activities
-2.07 -3.50 -1.38 -6.20 -0.66 -8.75 -10 -13 -24 -6.22 -14
Repurchase of Common Equity
- - 0.00 -3.40 - -7.54 -6.86 -11 -7.47 -2.93 -9.80
Other Financing Activities, net
-2.07 -3.24 -1.38 -2.75 -0.66 -1.21 -3.21 -1.73 -0.91 -3.28 -4.54
Effect of Exchange Rate Changes
- - - - -0.42 0.41 -0.14 -0.07 0.66 0.03 -0.03

Annual Balance Sheets for Angi

This table presents Angi's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
296 1,467 1,808 1,922 2,368 2,012 1,908 1,856 1,831
Total Current Assets
64 262 474 500 978 585 484 487 495
Cash & Equivalents
36 222 337 391 813 428 321 364 416
Accounts Receivable
19 28 27 42 43 86 72 51 37
Other Current Assets
8.74 13 85 68 72 71 64 72 42
Plant, Property, & Equipment, net
24 53 71 103 109 118 153 110 80
Total Noncurrent Assets
208 1,152 1,263 1,318 1,282 1,309 1,271 1,259 1,256
Goodwill
171 770 895 884 892 916 883 886 883
Intangible Assets
11 329 304 252 210 194 178 171 168
Noncurrent Deferred & Refundable Income Taxes
15 51 41 - 86 123 138 148 169
Other Noncurrent Operating Assets
11 2.07 23 183 94 76 62 54 36
Total Liabilities & Shareholders' Equity
296 1,467 1,808 1,922 2,368 2,012 1,908 1,856 1,831
Total Liabilities
119 443 468 571 1,059 867 856 812 768
Total Current Liabilities
68 171 201 215 234 278 282 259 232
Accounts Payable
14 20 20 26 31 39 30 29 18
Accrued Expenses
34 75 106 117 148 186 183 179 171
Current Deferred Revenue
19 62 61 58 55 54 50 50 42
Total Noncurrent Liabilities
51 272 267 356 825 588 575 553 536
Long-Term Debt
0.00 258 245 232 712 495 495 496 497
Noncurrent Deferred & Payable Income Tax Liabilities
2.23 5.63 3.81 3.44 1.30 1.88 2.91 2.74 1.50
Other Noncurrent Operating Liabilities
2.25 5.89 17 121 112 92 76 54 38
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
163 1,003 1,322 1,324 1,283 1,146 1,051 1,045 1,063
Total Preferred & Common Equity
153 993 1,313 1,314 1,272 1,135 1,048 1,041 1,063
Total Common Equity
153 993 1,313 1,314 1,272 1,135 1,048 1,041 1,063
Common Stock
155 1,112 1,334 1,358 1,380 1,351 1,406 1,448 1,466
Retained Earnings
0.00 -122 -19 16 9.75 -62 -190 -231 -195
Treasury Stock
- - 0.00 -58 -122 -158 -166 -177 -206
Accumulated Other Comprehensive Income / (Loss)
-1.72 2.23 -1.86 -1.38 4.64 3.31 -1.17 1.19 -2.50

Quarterly Balance Sheets for Angi

This table presents Angi's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets
2,018 1,968 1,889 1,902 1,906 1,835 1,852 1,856 1,806
Total Current Assets
563 512 486 511 516 482 516 500 465
Cash & Equivalents
361 329 315 371 367 363 385 395 387
Accounts Receivable
120 103 92 78 77 61 66 52 40
Other Current Assets
82 81 67 62 72 58 65 52 38
Plant, Property, & Equipment, net
156 167 139 130 121 100 90 86 84
Total Noncurrent Assets
1,299 1,288 1,264 1,261 1,269 1,253 1,247 1,271 1,256
Goodwill
910 903 884 886 883 885 885 888 886
Intangible Assets
185 180 176 173 170 171 171 171 168
Noncurrent Deferred & Refundable Income Taxes
135 137 144 149 158 147 147 172 170
Other Noncurrent Operating Assets
68 69 60 53 56 50 44 40 33
Total Liabilities & Shareholders' Equity
2,018 1,968 1,889 1,902 1,906 1,835 1,852 1,856 1,806
Total Liabilities
918 880 841 860 860 792 808 787 756
Total Current Liabilities
338 300 270 303 304 242 261 244 216
Accounts Payable
42 50 31 37 53 31 21 33 29
Accrued Expenses
239 194 189 212 196 162 189 160 152
Current Deferred Revenue
57 55 50 54 55 50 51 50 35
Total Noncurrent Liabilities
580 580 570 557 557 550 548 543 540
Long-Term Debt
495 495 495 496 496 496 496 497 497
Noncurrent Deferred & Payable Income Tax Liabilities
2.22 1.66 2.93 3.01 2.92 3.03 3.30 2.05 1.53
Other Noncurrent Operating Liabilities
83 83 72 58 58 50 48 44 42
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,100 1,088 1,048 1,042 1,045 1,043 1,044 1,070 1,049
Total Preferred & Common Equity
1,089 1,086 1,045 1,038 1,042 1,039 1,040 1,070 1,049
Total Common Equity
1,089 1,086 1,045 1,038 1,042 1,039 1,040 1,070 1,049
Common Stock
1,375 1,394 1,417 1,427 1,438 1,455 1,464 1,463 1,445
Retained Earnings
-119 -137 -205 -220 -225 -233 -229 -194 -180
Treasury Stock
-166 -166 -166 -170 -170 -184 -195 -203 -217
Accumulated Other Comprehensive Income / (Loss)
-0.39 -5.21 -0.71 1.12 -0.94 0.44 0.26 3.28 0.38

Annual Metrics And Ratios for Angi

This table displays calculated financial ratios and metrics derived from Angi's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
0.00% 38.12% 47.60% 53.76% 17.13% 10.69% 10.31% 8.96% -22.99% -12.78%
EBITDA Growth
0.00% 312.80% -409.45% 255.58% -16.43% -36.56% -94.73% 258.81% 454.97% 37.87%
EBIT Growth
0.00% 1,288.15% -724.59% 155.96% -44.71% -114.11% -1,005.95% -5.71% 89.16% 598.65%
NOPAT Growth
0.00% 1,137.25% -1,009.19% 168.34% -42.66% -110.99% -966.54% -11.34% 64.96% 316.55%
Net Income Growth
0.00% 366.04% -1,083.23% 174.15% -54.44% -115.23% -1,210.78% -81.55% 68.50% 191.41%
EPS Growth
0.00% 0.00% -900.00% 162.50% -53.33% -114.29% -1,300.00% -85.71% 69.23% 187.50%
Operating Cash Flow Growth
0.00% 167.80% -12.68% 434.87% -4.26% -12.02% -96.70% 335.96% 287.33% 48.73%
Free Cash Flow Firm Growth
0.00% 0.00% -465.63% 90.91% 181.04% -42.48% -339.22% 51.26% 126.54% 464.01%
Invested Capital Growth
0.00% 0.00% 475.85% 14.95% -2.63% -3.86% 4.59% -0.32% -2.61% -2.83%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 5.18% 3.31% 2.64% -0.59% -1.96% -1.02% -2.67%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 64.82% -12.21% -19.25% -80.53% 230.39% 36.34% -6.31%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 446.06% -35.48% -190.80% -34.68% 13.65% 81.59% -16.02%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 206.77% -38.08% -115.19% -29.88% 12.30% 39.56% 0.40%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 542.87% -51.07% -137.21% -9.03% -27.36% 54.21% 13.07%
EPS Q/Q Growth
0.00% 0.00% 0.00% 400.00% -50.00% -200.00% -27.27% -30.00% 55.56% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 60.15% -15.04% -8.21% -84.90% 425.31% 0.32% 28.57%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 239.60% -56.25% -7.08% 60.44% -73.84% 69.29%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 14.35% 0.40% 2.22% 1.75% -3.72% 0.19% -2.37%
Profitability Metrics
- - - - - - - - - -
Gross Margin
93.65% 94.82% 95.37% 95.08% 96.49% 88.20% 83.04% 80.88% 95.40% 95.14%
EBITDA Margin
2.34% 7.00% -14.68% 14.85% 10.60% 6.07% 0.29% 0.95% 6.88% 10.88%
Operating Margin
-0.43% 4.82% -20.08% 5.64% 2.91% -0.43% -4.19% -4.29% -1.95% 1.85%
EBIT Margin
-0.54% 4.68% -19.81% 7.21% 3.40% -0.43% -4.35% -4.22% -0.59% 3.40%
Profit (Net Income) Margin
-1.11% 2.13% -14.19% 6.85% 2.66% -0.37% -4.35% -7.25% -2.97% 3.11%
Tax Burden Percent
178.55% 47.32% 68.04% 110.69% 104.96% 27.82% 75.06% 135.35% 142.91% 183.53%
Interest Burden Percent
113.84% 96.17% 105.30% 85.76% 74.54% 303.52% 133.35% 127.01% 349.50% 49.89%
Effective Tax Rate
0.00% 52.68% 0.00% -10.69% -4.96% 0.00% 0.00% 0.00% 0.00% -83.53%
Return on Invested Capital (ROIC)
0.00% 12.18% -16.38% 6.11% 3.32% -0.38% -4.01% -4.37% -1.56% 3.46%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -2.02% -19.60% -21.16% 7.57% 0.25% 50.63% -71.64% -16.63% 0.34%
Return on Net Nonoperating Assets (RNNOA)
0.00% -0.12% -1.03% 0.44% -0.69% -0.03% -1.73% -7.28% -2.29% 0.03%
Return on Equity (ROE)
0.00% 12.05% -17.41% 6.56% 2.63% -0.40% -5.74% -11.65% -3.85% 3.50%
Cash Return on Invested Capital (CROIC)
0.00% -187.82% -157.19% -7.80% 5.99% 3.56% -8.49% -4.06% 1.09% 6.33%
Operating Return on Assets (OROA)
0.00% 7.90% -16.55% 4.99% 2.42% -0.30% -3.22% -3.80% -0.43% 2.18%
Return on Assets (ROA)
0.00% 3.60% -11.86% 4.73% 1.89% -0.25% -3.22% -6.53% -2.14% 2.00%
Return on Common Equity (ROCE)
0.00% 10.46% -16.62% 6.39% 2.56% -0.39% -5.63% -11.58% -3.83% 3.49%
Return on Equity Simple (ROE_SIMPLE)
0.00% 6.94% -10.52% 5.90% 2.69% -0.42% -6.21% -12.21% -3.87% 3.47%
Net Operating Profit after Tax (NOPAT)
-1.10 11 -104 71 41 -4.46 -48 -53 -19 40
NOPAT Margin
-0.30% 2.28% -14.06% 6.25% 3.06% -0.30% -2.94% -3.00% -1.37% 3.39%
Net Nonoperating Expense Percent (NNEP)
0.00% 14.19% 3.22% 27.27% -4.25% -0.62% -54.64% 67.27% 15.08% 3.12%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - -3.42% -1.20% 2.58%
Cost of Revenue to Revenue
6.35% 5.18% 4.63% 4.92% 3.51% 11.80% 16.96% 19.12% 4.60% 4.86%
SG&A Expenses to Revenue
24.00% 22.07% 40.80% 28.57% 26.26% 25.48% 24.39% 25.34% 26.45% 27.00%
R&D to Revenue
4.66% 4.13% 6.51% 5.40% 4.84% 4.69% 4.38% 4.18% 7.11% 8.05%
Operating Expenses to Revenue
94.08% 89.99% 115.45% 89.43% 93.58% 88.63% 87.23% 85.16% 97.35% 93.29%
Earnings before Interest and Taxes (EBIT)
-1.97 23 -146 82 45 -6.37 -70 -74 -8.07 40
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
8.46 35 -108 168 141 89 4.70 17 93 129
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 6.07 3.24 5.18 4.08 1.13 1.21 0.78
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 69.94 23.84 38.62 186.92 0.00 0.00 70.56
Price to Revenue (P/Rev)
0.00 0.00 0.00 7.04 3.21 4.49 2.86 0.67 0.93 0.70
Price to Earnings (P/E)
0.00 0.00 0.00 103.06 122.28 0.00 0.00 0.00 0.00 22.93
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.97% 0.82% 0.00% 0.00% 0.00% 0.00% 4.36%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 6.38 3.44 5.59 3.88 1.13 1.19 0.79
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 6.97 3.13 4.42 2.91 0.77 1.03 0.76
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 46.93 29.53 72.70 1,001.99 80.89 14.96 7.03
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 96.66 91.93 0.00 0.00 0.00 0.00 22.51
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 111.58 102.31 0.00 0.00 0.00 0.00 22.55
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 35.28 19.38 34.40 757.67 50.34 13.34 5.81
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 56.71 153.99 0.00 0.00 107.36 12.33
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.00 0.00 0.27 0.19 0.18 0.54 0.43 0.47 0.47 0.47
Long-Term Debt to Equity
0.00 0.00 0.25 0.18 0.17 0.54 0.43 0.47 0.47 0.47
Financial Leverage
0.00 0.06 0.05 -0.02 -0.09 -0.11 -0.03 0.10 0.14 0.10
Leverage Ratio
0.00 1.68 1.47 1.39 1.39 1.61 1.78 1.78 1.80 1.75
Compound Leverage Factor
0.00 1.61 1.55 1.19 1.03 4.90 2.38 2.27 6.28 0.87
Debt to Total Capital
0.00% 0.00% 20.99% 16.18% 15.40% 35.24% 30.15% 32.02% 32.20% 31.86%
Short-Term Debt to Total Capital
0.00% 0.00% 1.06% 0.86% 0.86% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 19.92% 15.32% 14.53% 35.24% 30.15% 32.02% 32.20% 31.86%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 13.19% 2.39% 1.70% 2.25% 1.83% 0.67% 0.19% 0.24% 0.00%
Common Equity to Total Capital
0.00% 86.81% 76.58% 82.12% 82.35% 62.94% 69.18% 67.78% 67.56% 68.14%
Debt to EBITDA
0.00 0.00 -2.52 1.54 1.75 7.99 105.34 29.40 5.31 3.85
Net Debt to EBITDA
0.00 0.00 -0.47 -0.61 -1.03 -1.69 14.15 10.34 1.41 0.62
Long-Term Debt to EBITDA
0.00 0.00 -2.39 1.46 1.65 7.99 105.34 29.40 5.31 3.85
Debt to NOPAT
0.00 0.00 -2.63 3.66 6.06 -159.79 -10.40 -9.36 -26.74 12.37
Net Debt to NOPAT
0.00 0.00 -0.49 -1.46 -3.57 33.75 -1.40 -3.29 -7.12 2.00
Long-Term Debt to NOPAT
0.00 0.00 -2.50 3.46 5.72 -159.79 -10.40 -9.36 -26.74 12.37
Altman Z-Score
0.00 0.00 0.00 11.16 5.43 4.73 4.03 1.61 1.62 1.39
Noncontrolling Interest Sharing Ratio
0.00% 13.19% 4.56% 2.48% 2.35% 2.74% 1.95% 0.63% 0.32% 0.18%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
0.00 0.94 1.53 2.36 2.33 4.18 2.10 1.72 1.88 2.14
Quick Ratio
0.00 0.81 1.46 1.93 2.01 3.88 1.85 1.40 1.61 1.96
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -176 -993 -90 73 42 -101 -49 13 73
Operating Cash Flow to CapEx
175.86% 287.49% 155.84% 611.80% 311.26% 359.11% 8.88% 23.47% 219.82% 309.34%
Free Cash Flow to Firm to Interest Expense
0.00 -196.46 -128.42 -7.77 6.37 2.97 -4.29 -2.44 0.65 3.64
Operating Cash Flow to Interest Expense
65.75 53.57 5.41 19.25 18.63 13.29 0.26 1.35 5.21 7.73
Operating Cash Flow Less CapEx to Interest Expense
28.36 34.94 1.94 16.10 12.65 9.59 -2.71 -4.39 2.84 5.23
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.00 1.69 0.84 0.69 0.71 0.68 0.74 0.90 0.72 0.64
Accounts Receivable Turnover
0.00 26.68 31.48 40.91 38.48 34.61 25.02 22.29 22.08 27.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 21.10 19.14 18.24 15.22 13.84 14.26 13.03 10.37 12.53
Accounts Payable Turnover
0.00 1.80 2.00 2.80 2.02 6.10 7.89 9.74 2.09 2.41
Days Sales Outstanding (DSO)
0.00 13.68 11.59 8.92 9.49 10.54 14.59 16.37 16.53 13.52
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 203.01 182.81 130.42 180.84 59.81 46.29 37.46 174.66 151.46
Cash Conversion Cycle (CCC)
0.00 -189.33 -171.22 -121.50 -171.35 -49.27 -31.70 -21.09 -158.13 -137.95
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
0.00 187 1,077 1,238 1,205 1,159 1,212 1,208 1,177 1,143
Invested Capital Turnover
0.00 5.34 1.17 0.98 1.09 1.24 1.37 1.46 1.14 1.02
Increase / (Decrease) in Invested Capital
0.00 187 890 161 -33 -47 53 -3.86 -32 -33
Enterprise Value (EV)
0.00 0.00 0.00 7,892 4,150 6,481 4,704 1,363 1,399 906
Market Capitalization
0.00 0.00 0.00 7,968 4,259 6,595 4,627 1,186 1,263 825
Book Value per Share
$0.00 $0.35 $2.31 $2.65 $2.61 $2.55 $2.26 $2.08 $2.05 $2.14
Tangible Book Value per Share
$0.00 ($0.07) ($0.25) $0.23 $0.36 $0.34 $0.05 ($0.03) ($0.03) $0.02
Total Capital
0.00 176 1,296 1,599 1,596 2,021 1,640 1,547 1,541 1,560
Total Debt
0.00 0.00 272 259 246 712 495 495 496 497
Total Long-Term Debt
0.00 0.00 258 245 232 712 495 495 496 497
Net Debt
0.00 -36 51 -103 -145 -150 66 174 132 80
Capital Expenditures (CapEx)
10 17 27 37 69 52 70 115 48 50
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -40 -116 -75 -92 -119 -122 -119 -135 -153
Debt-free Net Working Capital (DFNWC)
0.00 -3.84 105 287 299 744 307 202 229 263
Net Working Capital (NWC)
0.00 -3.84 91 273 285 744 307 202 229 263
Net Nonoperating Expense (NNE)
2.90 0.75 1.02 -6.77 5.25 0.92 23 75 22 3.32
Net Nonoperating Obligations (NNO)
0.00 11 53 -102 -145 -150 66 157 132 80
Total Depreciation and Amortization (D&A)
10 12 38 87 95 96 75 91 102 89
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -8.06% -15.81% -6.65% -6.92% -8.08% -7.51% -6.73% -9.97% -12.91%
Debt-free Net Working Capital to Revenue
0.00% -0.77% 14.27% 25.32% 22.53% 50.69% 18.93% 11.47% 16.82% 22.23%
Net Working Capital to Revenue
0.00% -0.77% 12.40% 24.10% 21.49% 50.69% 18.93% 11.47% 16.82% 22.23%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.03 ($0.24) $0.16 $0.07 ($0.01) ($0.14) ($0.26) ($0.08) $0.07
Adjusted Weighted Average Basic Shares Outstanding
0.00 437.60M 478.25M 504.04M 501.14M 500.05M 501.63M 504.78M 502.03M 498.45M
Adjusted Diluted Earnings per Share
$0.00 $0.03 ($0.24) $0.15 $0.07 ($0.01) ($0.14) ($0.26) ($0.08) $0.07
Adjusted Weighted Average Diluted Shares Outstanding
0.00 437.60M 478.25M 504.04M 501.14M 500.05M 501.63M 504.78M 502.03M 498.45M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.03 $0.00 $0.00 $0.07 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 437.60M 478.25M 504.04M 501.14M 500.05M 501.63M 504.78M 502.03M 498.45M
Normalized Net Operating Profit after Tax (NOPAT)
-1.10 17 -104 45 27 -4.46 -48 -53 -19 15
Normalized NOPAT Margin
-0.30% 3.38% -14.06% 3.95% 2.04% -0.30% -2.94% -3.00% -1.37% 1.29%
Pre Tax Income Margin
-0.62% 4.50% -20.86% 6.18% 2.54% -1.32% -5.80% -5.36% -2.08% 1.69%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
-7.23 26.13 -18.86 7.02 3.93 -0.45 -3.00 -3.70 -0.40 2.00
NOPAT to Interest Expense
-4.04 12.73 -13.38 6.09 3.53 -0.31 -2.02 -2.63 -0.92 1.99
EBIT Less CapEx to Interest Expense
-44.62 7.49 -22.33 3.88 -2.06 -4.15 -5.98 -9.44 -2.77 -0.50
NOPAT Less CapEx to Interest Expense
-41.43 -5.90 -16.85 2.94 -2.46 -4.02 -5.00 -8.37 -3.29 -0.51
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 1.97% -12.24% 7.82% 0.20% -79.60% -39.52% 0.00% 0.00% 43.47%
Augmented Payout Ratio
0.00% 1.97% -12.24% 7.82% 161.34% -1,263.57% -89.74% -6.36% -27.12% 121.10%

Quarterly Metrics And Ratios for Angi

This table displays calculated financial ratios and metrics derived from Angi's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.90% -10.11% -18.49% -31.83% -29.48% -4.44% -14.09% -10.37% -15.52% -10.84% -19.48%
EBITDA Growth
164.58% 700.50% 228.62% 364.15% 157.66% 48.04% 49.43% 163.17% 48.27% -23.42% 12.01%
EBIT Growth
13.58% 53.61% 79.17% 54.95% 70.26% 235.53% 201.78% 234.91% 447.33% -58.30% 244.88%
NOPAT Growth
26.15% 52.18% 67.96% 26.36% 28.90% 134.21% 78.28% 140.02% 673.98% -367.00% 1,023.01%
Net Income Growth
-4.47% -106.73% 54.94% 39.66% 69.68% 89.59% 91.22% 128.23% 768.87% 76.81% 1,247.00%
EPS Growth
0.00% -120.00% 57.14% 40.00% 66.67% 90.91% 100.00% 133.33% 800.00% 0.00% 1,100.00%
Operating Cash Flow Growth
112.82% 179.84% 2,980.54% 624.43% 157.51% 2.14% 5.31% 10.75% 180.57% 149.50% -113.96%
Free Cash Flow Firm Growth
-5.22% 95.63% 91.79% 145.04% 204.94% 1,250.69% 736.21% -72.21% -53.34% -20.10% -18.19%
Invested Capital Growth
5.35% -0.32% -0.13% -5.42% -6.41% -2.61% -3.32% -0.97% -0.29% -2.83% -1.40%
Revenue Q/Q Growth
-3.44% -36.88% 13.08% -1.10% -0.10% -14.46% 9.14% 3.19% -5.84% -9.72% -8.20%
EBITDA Q/Q Growth
249.87% 205.15% -17.06% -30.36% 46.19% 75.33% -20.00% 22.65% -17.64% -9.44% 22.44%
EBIT Q/Q Growth
41.01% 27.22% 27.21% -44.15% 61.05% 431.62% -53.30% 91.07% 0.28% -60.18% 352.05%
NOPAT Q/Q Growth
47.06% 12.11% -11.96% -41.36% 48.89% 142.29% -136.11% 360.44% 633.10% -119.67% 345.72%
Net Income Q/Q Growth
27.33% -205.40% 71.84% 3.47% 63.49% -4.88% 76.25% 410.40% 765.04% -103.64% 1,274.65%
EPS Q/Q Growth
40.00% -266.67% 72.73% 0.00% 66.67% 0.00% 100.00% 0.00% 600.00% -114.29% 3,100.00%
Operating Cash Flow Q/Q Growth
-45.24% 267.17% 34.76% 167.37% -80.53% 45.63% 313.96% 181.18% -50.69% 29.50% -107.78%
Free Cash Flow Firm Q/Q Growth
42.64% 95.88% -106.72% 1,021.13% 33.64% -54.78% 7.17% -59.76% 124.35% -22.56% 17.02%
Invested Capital Q/Q Growth
1.70% -3.72% 0.68% -4.06% 0.63% 0.19% -0.05% -1.72% 1.32% -2.37% 1.43%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
78.10% 99.50% 95.24% 95.82% 96.11% 94.26% 95.91% 95.51% 95.03% 93.96% 94.71%
EBITDA Margin
1.65% 7.97% 5.84% 4.12% 6.02% 12.35% 10.17% 12.08% 10.57% 10.60% 14.14%
Operating Margin
-2.22% -3.09% -3.06% -4.37% -2.24% 2.54% 0.89% 2.92% 2.63% 0.81% 8.13%
EBIT Margin
-2.68% -3.09% -1.99% -2.90% -1.13% 4.38% 2.36% 4.37% 4.65% 2.05% 10.10%
Profit (Net Income) Margin
-3.50% -16.94% -4.22% -4.12% -1.51% -1.85% -0.43% 1.30% 11.92% -0.48% 6.14%
Tax Burden Percent
94.86% 582.57% 123.94% 95.06% 58.69% -68.16% -60.92% 46.90% 404.10% -287.05% 76.34%
Interest Burden Percent
137.67% 94.06% 171.09% 149.37% 226.81% 61.76% 30.03% 63.36% 63.43% 8.16% 79.69%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 69.48% 160.92% 53.10% -304.10% 387.05% 23.66%
Return on Invested Capital (ROIC)
-2.29% -3.16% -2.96% -3.88% -1.77% 0.88% -0.59% 1.50% 11.06% -2.37% 5.99%
ROIC Less NNEP Spread (ROIC-NNEP)
-12.83% -44.80% -8.40% -6.74% -1.62% -4.57% -0.37% 1.31% 14.33% 2.27% 5.85%
Return on Net Nonoperating Assets (RNNOA)
-1.04% -4.55% -1.05% -0.82% -0.22% -0.63% -0.05% 0.15% 1.56% 0.23% 0.68%
Return on Equity (ROE)
-3.33% -7.71% -4.02% -4.69% -2.00% 0.25% -0.65% 1.65% 12.62% -2.14% 6.67%
Cash Return on Invested Capital (CROIC)
-10.14% -4.06% -2.90% 2.83% 4.10% 1.09% 2.62% 1.20% 3.70% 6.33% 6.15%
Operating Return on Assets (OROA)
-2.39% -2.78% -1.72% -2.25% -0.80% 3.17% 1.66% 2.96% 3.01% 1.32% 6.24%
Return on Assets (ROA)
-3.12% -15.25% -3.65% -3.19% -1.07% -1.33% -0.30% 0.88% 7.72% -0.31% 3.80%
Return on Common Equity (ROCE)
-3.30% -7.66% -3.99% -4.66% -1.99% 0.25% -0.64% 1.64% 12.60% -2.14% 6.65%
Return on Equity Simple (ROE_SIMPLE)
-9.26% 0.00% -10.50% -9.65% -8.45% 0.00% -2.56% -0.78% 3.05% 0.00% 5.08%
Net Operating Profit after Tax (NOPAT)
-7.74 -6.80 -7.62 -11 -5.50 2.33 -1.65 4.31 32 -6.21 15
NOPAT Margin
-1.55% -2.16% -2.14% -3.06% -1.57% 0.77% -0.54% 1.37% 10.65% -2.32% 6.21%
Net Nonoperating Expense Percent (NNEP)
10.54% 41.64% 5.44% 2.87% -0.15% 5.45% -0.22% 0.19% -3.28% -4.64% 0.14%
Return On Investment Capital (ROIC_SIMPLE)
- -0.44% - - - 0.15% - - - -0.40% 0.99%
Cost of Revenue to Revenue
21.90% 0.50% 4.76% 4.18% 3.89% 5.74% 4.09% 4.49% 4.97% 6.04% 5.29%
SG&A Expenses to Revenue
25.75% 28.50% 27.19% 26.50% 28.10% 23.58% 28.00% 26.77% 25.89% 27.36% 23.31%
R&D to Revenue
3.18% 6.10% 7.12% 7.27% 6.12% 8.05% 7.78% 7.86% 8.19% 8.40% 11.01%
Operating Expenses to Revenue
80.32% 102.59% 98.30% 100.19% 98.35% 91.72% 95.02% 92.59% 92.39% 93.15% 86.57%
Earnings before Interest and Taxes (EBIT)
-13 -9.72 -7.07 -10 -3.97 13 7.20 14 14 5.49 25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
8.21 25 21 14 21 37 31 38 31 28 35
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.37 1.13 1.10 1.61 0.96 1.21 1.27 0.93 1.20 0.78 0.73
Price to Tangible Book Value (P/TBV)
596.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00 125.74 70.56 0.00
Price to Revenue (P/Rev)
0.83 0.67 0.68 1.10 0.73 0.93 1.01 0.76 1.06 0.70 0.68
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 40.55 22.93 14.56
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.47% 4.36% 6.87%
Enterprise Value to Invested Capital (EV/IC)
1.32 1.13 1.08 1.54 0.97 1.19 1.24 0.93 1.19 0.79 0.76
Enterprise Value to Revenue (EV/Rev)
0.92 0.77 0.78 1.18 0.83 1.03 1.11 0.85 1.14 0.76 0.78
Enterprise Value to EBITDA (EV/EBITDA)
0.00 80.89 26.99 29.13 16.55 14.96 14.00 8.47 10.09 7.03 6.76
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 234.12 35.79 28.96 22.51 15.18
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 401.99 34.69 22.55 15.87
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 50.34 26.90 18.41 10.86 13.34 15.24 10.64 11.44 5.81 6.73
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 53.04 22.80 107.36 46.29 77.26 31.98 12.33 12.24
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.45 0.47 0.47 0.48 0.47 0.47 0.48 0.48 0.46 0.47 0.47
Long-Term Debt to Equity
0.45 0.47 0.47 0.48 0.47 0.47 0.48 0.48 0.46 0.47 0.47
Financial Leverage
0.08 0.10 0.13 0.12 0.14 0.14 0.14 0.11 0.11 0.10 0.12
Leverage Ratio
1.79 1.78 1.80 1.83 1.82 1.80 1.78 1.80 1.78 1.75 1.74
Compound Leverage Factor
2.46 1.68 3.08 2.73 4.12 1.11 0.53 1.14 1.13 0.14 1.39
Debt to Total Capital
31.26% 32.02% 32.09% 32.24% 32.17% 32.20% 32.24% 32.22% 31.71% 31.86% 32.15%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
31.26% 32.02% 32.09% 32.24% 32.17% 32.20% 32.24% 32.22% 31.71% 31.86% 32.15%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.18% 0.19% 0.22% 0.24% 0.23% 0.24% 0.26% 0.28% 0.00% 0.00% 0.00%
Common Equity to Total Capital
68.55% 67.78% 67.69% 67.53% 67.59% 67.56% 67.50% 67.49% 68.29% 68.14% 67.85%
Debt to EBITDA
-38.32 29.40 10.15 8.02 7.23 5.31 4.78 3.90 3.61 3.85 3.82
Net Debt to EBITDA
-12.87 10.34 3.44 2.02 1.88 1.41 1.28 0.88 0.74 0.62 0.85
Long-Term Debt to EBITDA
-38.32 29.40 10.15 8.02 7.23 5.31 4.78 3.90 3.61 3.85 3.82
Debt to NOPAT
-8.20 -9.36 -13.47 -15.05 -16.16 -26.74 -54.95 184.92 12.41 12.37 8.98
Net Debt to NOPAT
-2.76 -3.29 -4.57 -3.80 -4.20 -7.12 -14.72 41.55 2.53 2.00 2.00
Long-Term Debt to NOPAT
-8.20 -9.36 -13.47 -15.05 -16.16 -26.74 -54.95 184.92 12.41 12.37 8.98
Altman Z-Score
1.94 1.73 1.68 1.92 1.38 1.66 1.70 1.42 1.68 1.33 1.30
Noncontrolling Interest Sharing Ratio
0.81% 0.63% 0.67% 0.68% 0.30% 0.32% 0.35% 0.38% 0.17% 0.18% 0.19%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.71 1.72 1.80 1.69 1.70 1.88 1.99 1.98 2.05 2.14 2.15
Quick Ratio
1.44 1.40 1.55 1.48 1.46 1.61 1.75 1.73 1.84 1.96 1.98
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-71 -2.95 -6.09 56 75 34 39 16 35 27 32
Operating Cash Flow to CapEx
12.84% 78.48% 178.64% 541.59% 79.91% 138.32% 174.30% 495.75% 255.44% 311.09% -24.91%
Free Cash Flow to Firm to Interest Expense
-14.20 -0.59 -1.21 11.14 14.89 6.73 7.69 3.09 6.93 5.37 6.28
Operating Cash Flow to Interest Expense
0.85 3.12 4.21 11.24 2.19 3.19 4.43 12.44 6.13 7.94 -0.62
Operating Cash Flow Less CapEx to Interest Expense
-5.77 -0.86 1.85 9.17 -0.55 0.88 1.89 9.93 3.73 5.38 -3.10
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.89 0.90 0.86 0.78 0.71 0.72 0.70 0.68 0.65 0.64 0.62
Accounts Receivable Turnover
17.86 22.29 17.51 15.33 15.23 22.08 17.09 17.57 18.78 27.00 22.23
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
12.67 13.03 12.15 10.63 9.51 10.37 10.95 11.60 11.77 12.53 12.25
Accounts Payable Turnover
8.63 9.74 5.83 3.62 0.91 2.09 1.89 1.99 1.36 2.41 1.96
Days Sales Outstanding (DSO)
20.43 16.37 20.85 23.81 23.96 16.53 21.35 20.77 19.43 13.52 16.42
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
42.32 37.46 62.59 100.86 401.55 174.66 193.32 183.51 267.46 151.46 186.02
Cash Conversion Cycle (CCC)
-21.88 -21.09 -41.75 -77.05 -377.59 -158.13 -171.96 -162.73 -248.03 -137.95 -169.60
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,255 1,208 1,216 1,167 1,174 1,177 1,176 1,156 1,171 1,143 1,160
Invested Capital Turnover
1.47 1.46 1.38 1.27 1.13 1.14 1.09 1.10 1.04 1.02 0.96
Increase / (Decrease) in Invested Capital
64 -3.86 -1.53 -67 -80 -32 -40 -11 -3.39 -33 -16
Enterprise Value (EV)
1,654 1,363 1,317 1,800 1,135 1,399 1,452 1,079 1,388 906 879
Market Capitalization
1,485 1,186 1,146 1,672 1,002 1,263 1,315 963 1,287 825 768
Book Value per Share
$2.16 $2.08 $2.07 $2.05 $2.06 $2.05 $2.07 $2.07 $2.14 $2.14 $2.10
Tangible Book Value per Share
$0.00 ($0.03) ($0.03) ($0.04) ($0.02) ($0.03) ($0.03) ($0.03) $0.02 $0.02 ($0.01)
Total Capital
1,584 1,547 1,544 1,538 1,541 1,541 1,539 1,541 1,566 1,560 1,546
Total Debt
495 495 495 496 496 496 496 496 497 497 497
Total Long-Term Debt
495 495 495 496 496 496 496 496 497 497 497
Net Debt
166 174 168 125 129 132 133 112 101 80 110
Capital Expenditures (CapEx)
33 20 12 10 14 12 13 13 12 13 12
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-116 -119 -111 -163 -155 -135 -124 -130 -139 -153 -137
Debt-free Net Working Capital (DFNWC)
212 202 216 208 212 229 240 255 256 263 249
Net Working Capital (NWC)
212 202 216 208 212 229 240 255 256 263 249
Net Nonoperating Expense (NNE)
9.70 46 7.38 3.71 -0.22 7.87 -0.34 0.22 -3.77 -4.93 0.16
Net Nonoperating Obligations (NNO)
166 157 168 125 129 132 133 112 101 80 110
Total Depreciation and Amortization (D&A)
22 35 28 25 25 24 24 24 18 23 9.95
Debt-free, Cash-free Net Working Capital to Revenue
-6.47% -6.73% -6.61% -10.70% -11.27% -9.97% -9.46% -10.19% -11.44% -12.91% -12.21%
Debt-free Net Working Capital to Revenue
11.80% 11.47% 12.84% 13.68% 15.45% 16.82% 18.31% 20.06% 21.02% 22.23% 22.14%
Net Working Capital to Revenue
11.80% 11.47% 12.84% 13.68% 15.45% 16.82% 18.31% 20.06% 21.02% 22.23% 22.14%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.03) ($0.11) ($0.03) ($0.03) ($0.01) ($0.01) $0.00 $0.01 $0.07 ($0.01) $0.30
Adjusted Weighted Average Basic Shares Outstanding
504.47M 504.78M 506.57M 506.28M 507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M
Adjusted Diluted Earnings per Share
($0.03) ($0.11) ($0.03) ($0.03) ($0.01) ($0.01) $0.00 $0.01 $0.07 ($0.01) $0.30
Adjusted Weighted Average Diluted Shares Outstanding
504.47M 504.78M 506.57M 506.28M 507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
504.47M 504.78M 506.57M 506.28M 507.16M 502.03M 501.74M 498.67M 497.27M 498.45M 47.99M
Normalized Net Operating Profit after Tax (NOPAT)
-7.74 -6.80 -7.62 -11 -5.50 5.34 1.90 6.43 5.47 1.52 15
Normalized NOPAT Margin
-1.55% -2.16% -2.14% -3.06% -1.57% 1.78% 0.62% 2.04% 1.84% 0.57% 6.21%
Pre Tax Income Margin
-3.69% -2.91% -3.40% -4.33% -2.57% 2.71% 0.71% 2.77% 2.95% 0.17% 8.05%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-2.65 -1.93 -1.41 -2.03 -0.79 2.62 1.43 2.73 2.73 1.09 4.92
NOPAT to Interest Expense
-1.54 -1.35 -1.51 -2.14 -1.09 0.46 -0.33 0.85 6.26 -1.23 3.03
EBIT Less CapEx to Interest Expense
-9.28 -5.91 -3.76 -4.10 -3.53 0.31 -1.11 0.22 0.34 -1.46 2.44
NOPAT Less CapEx to Interest Expense
-8.16 -5.33 -3.87 -4.22 -3.83 -1.84 -2.87 -1.65 3.86 -3.78 0.55
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 49.15% 43.47% 0.00%
Augmented Payout Ratio
-8.10% -6.36% 0.00% -3.39% -3.86% -27.12% -66.82% -319.27% 151.06% 121.10% 59.22%

Key Financial Trends

Angi Inc. (NASDAQ: ANGI) reported mixed Q1 2025 results, with revenue coming in at $245.9 million, down 19.5 % year-over-year, but the company swung to positive net income of $15.1 million and strengthened its balance sheet. Gross margins remain very high, and leverage metrics have improved, while cash flow from operations moderated due to working-capital investments.

  • Swung to profitability: Q1 2025 net income of $15.1 M vs. a $1.3 M loss in Q1 2024.
  • High and expanding margins: Q1 2025 gross margin ~94.7 % and operating margin ~8.1 %, vs. ~0.8 % operating margin a year ago.
  • Debt reduction: Net debt down to ~$110 M (net debt/EBITDA ~0.85x), improving financial flexibility.
  • Attractive valuation: EV/EBITDA ~6.8x and P/E ~14.6x, well below historical levels.
  • Improved returns: Return on equity ~6.7 % vs. negative in prior-year quarter.
  • Balance‐sheet health: Altman Z-score ~1.30 remains borderline but stable.
  • Revenue decline: Q1 2025 revenue down 19.5 % YoY and down 8.2 % sequentially from Q4 2024.
  • High cost structure: Marketing (~48 % of revenue) and SG&A (~23 %) remain elevated.
  • Negative operating cash flow: OCF of –$3.1 M in Q1 2025 vs. +$22.3 M in Q1 2024, pressured by working-capital build.
  • Working capital drag: Large investment in receivables and other assets led to cash burn.
07/19/25 10:51 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Angi's Financials

When does Angi's financial year end?

According to the most recent income statement we have on file, Angi's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Angi's net income changed over the last 9 years?

Angi's net income appears to be on an upward trend, with a most recent value of $36.85 million in 2024, falling from -$4.00 million in 2015. The previous period was -$40.31 million in 2023. View Angi's forecast to see where analysts expect Angi to go next.

What is Angi's operating income?
Angi's total operating income in 2024 was $21.89 million, based on the following breakdown:
  • Total Gross Profit: $1.13 billion
  • Total Operating Expenses: $1.11 billion
How has Angi's revenue changed over the last 9 years?

Over the last 9 years, Angi's total revenue changed from $361.20 million in 2015 to $1.19 billion in 2024, a change of 228.1%.

How much debt does Angi have?

Angi's total liabilities were at $767.93 million at the end of 2024, a 5.4% decrease from 2023, and a 544.7% increase since 2016.

How much cash does Angi have?

In the past 8 years, Angi's cash and equivalents has ranged from $36.38 million in 2016 to $812.71 million in 2020, and is currently $416.43 million as of their latest financial filing in 2024.

How has Angi's book value per share changed over the last 9 years?

Over the last 9 years, Angi's book value per share changed from 0.00 in 2015 to 2.14 in 2024, a change of 213.7%.



This page (NASDAQ:ANGI) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners